# C_2021523EN.01000801.xml

| 28.12.2021 | EN | Official Journal of the European Union | C 523/8 |
| --- | --- | --- | --- |

28.12.2021

EN

Official Journal of the European Union

C 523/8

---

Prior notification of a concentration

(Case M.10585 – APMH INVEST / UNILABS)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 523/07)

1.

This notification concerns the following undertakings:

| — | APMH Invest A/S (‘APMHI’, Denmark), controlled by A.P. Møller Holding A/S (‘APMH’, Denmark); |
| --- | --- |

—

APMH Invest A/S (‘APMHI’, Denmark), controlled by A.P. Møller Holding A/S (‘APMH’, Denmark);

| — | Unilabs Holding AB (‘Unilabs’, Switzerland), controlled by Cidra GP S.à.r.l (Luxembourg). |
| --- | --- |

—

Unilabs Holding AB (‘Unilabs’, Switzerland), controlled by Cidra GP S.à.r.l (Luxembourg).

APMHI acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Unilabs.

The concentration is accomplished by way of purchase of shares.

2.

| — | for APMHI: globally active investment company, with investments in Maersk Tankers, Maersk Product Tankers, A.P. Moller Capital, KK Wind Solutions Holding A/S, Faerch, Nissens Cooling Solutions, Maersk Drilling, Danske Bank A/S and other financial investments in fixed income and securities. APHM also controls A.P. Møller-Mærsk A/S, an integrated transport and logistics company with worldwide activities. |
| --- | --- |

—

for APMHI: globally active investment company, with investments in Maersk Tankers, Maersk Product Tankers, A.P. Moller Capital, KK Wind Solutions Holding A/S, Faerch, Nissens Cooling Solutions, Maersk Drilling, Danske Bank A/S and other financial investments in fixed income and securities. APHM also controls A.P. Møller-Mærsk A/S, an integrated transport and logistics company with worldwide activities.

| — | for Unilabs: provider of diagnostic services, which is active in the provision of bio-medical testing services (also known as CLTS), medical imaging services, reproductive medicine services and drug development services. It has laboratories and/or imaging centres in several EU- and non-EU countries. |
| --- | --- |

—

for Unilabs: provider of diagnostic services, which is active in the provision of bio-medical testing services (also known as CLTS), medical imaging services, reproductive medicine services and drug development services. It has laboratories and/or imaging centres in several EU- and non-EU countries.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10585 – APMH INVEST / UNILABS

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---